ArticleJournal of medical case reports2025

Treatment-refractory immune checkpoint inhibitor-induced hemophagocytic lymphohistiocytosis in the setting of adjuvant pembrolizumab for resected stage IIC melanoma: a case report.

Kar Ven Cavan Chow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.